ÀRGENTIL INVESTS IN A PHARMACEUTICAL COMPANY
Àrgentil Capital Management Limited invested in Sygen Pharmaceuticals Limited through its investment vehicle, Consumer Growth Partners, alongside other co-investors. Sygen, established in 2019 by acquiring Nigerian German Chemicals’ assets, is a prominent player in Nigeria’s pharmaceutical sector. It operates from Ogun state with multiple depots nationwide, aiming to provide affordable, high-quality drugs to Nigeria’s middle and lower-income demographics.
Argentil’s investment was driven by Sygen’s management team’s extensive experience in FMCG operations across Nigeria and emerging markets, totaling over 155 years.
For more information, please visit
